Danaher Reports Q1 Earnings with Stronger Than Expected EPS and Mixed Segment Performance
Danaher reported Q1 sales of $6.0 billion with core revenue up 0.5% year-over-year and adjusted EPS of $2.06, up 9.5%. The company raised its full-year adjusted EPS guidance to $8.35–$8.55, though diagnostics faced challenges from Cepheid respiratory revenue decline and pricing pressures in China.
Topics: Earnings EPS Guidance Free Cash Flow M&A Revenue Growth Segment Performance